Neoadjuvant Treatment of Breast Cancer
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tamoxifen|DRUG: Goserelin|DRUG: Letrozole 2.5Mg Tab|DRUG: Epirubicin|DRUG: cyclophosphamide|DRUG: Docetaxel|DRUG: paclitaxel|DRUG: trastuzumab|DRUG: pertuzumab|DRUG: Capecitabine
Sponsor: National Institute of Oncology, Hungary